Saturday 29 June 2024

Contact Us

The Pharma Letter
39 to 43 Putney High Street
Putney
London
SW15 1SP

For trial and subscription enquiries please email subscriptions@thepharmaletter.com

For editorial enquiries, press releases and events please email newsdesk@thepharmaletter.com

For all other queries please email enquiries@thepharmaletter.com



Latest Features

Biotechnology
FDA slaps CRL on Rocket Pharma’s Kresladi
29 June 2024
Biotechnology
J&J moves Rybrevant into first-line setting with full EU approval
28 June 2024
Pharmaceutical
Latin America studies the adoption of regulatory reliance
28 June 2024
Pharmaceutical
EMA/CHMP June 2024 meeting highlights
28 June 2024


Today's issue

Biotechnology
FDA slaps CRL on Rocket Pharma’s Kresladi
29 June 2024
Biotechnology
J&J moves Rybrevant into first-line setting with full EU approval
28 June 2024
Pharmaceutical
Latin America studies the adoption of regulatory reliance
28 June 2024
Pharmaceutical
EMA/CHMP June 2024 meeting highlights
28 June 2024
Pharmaceutical
550 jobs to go at EUROAPI as part of new Sanofi deal
28 June 2024
Biotechnology
Peter Flyn joins Arialys as president and CEO
28 June 2024
Biotechnology
Alzheimer’s drug Leqembi launched in China
28 June 2024

Company Spotlight

A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze